MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.inpm.2022.100105

Медицинская библиотека · Interventional pain medicine · 2022

Encephalopathy after unintentional intrathecal gadolinium: A letter to the editor.

Moradian Maxim, Tekmyster Gene, Wei Jason J, Avetisian Henry, Acharya Jayant N, Furman Michael B

Письмо в редакциюПеревод в очереди

Аннотация

OBJECTIVE

Raise awareness of gadolinium encephalopathy, a rare cause of neurological symptoms.

SETTING

An L5-S1 interlaminar epidural steroid injection (IL-ESI) was performed with a gadolinium-based contrast agent (GBCA) due to the patient's history of allergic reaction to iodine-based contrast agents.

DISCUSSION: Several hours after administration of GBCA, the patient had nausea and vomiting with altered mental status. Patient was treated with dexamethasone IV, and was discharged on day 2. Patient had no residual deficits at follow-up two weeks later. Current literature shows that caution should be used to prevent inadvertent intrathecal GBCA, and doses >2.0 mmols are associated with serious adverse effects, including death.

CONCLUSIONS

Intrathecal administration of GBCAs should be limited to less than 0.5 mmol. If adverse effects are experienced, IV steroids should be administered as soon as possible, and a CSF drain should be considered.

Для цитирования: Moradian Maxim, Tekmyster Gene, Wei Jason J, Avetisian Henry, Acharya Jayant N, Furman Michael B. Encephalopathy after unintentional intrathecal gadolinium: A letter to the editor.. Interventional pain medicine. 2022. DOI: 10.1016/j.inpm.2022.100105.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.